TScan Therapeutics Inc. (TCRX)
undefined
undefined%
At close: undefined
2.85
-0.70%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -89.22M -66.22M -48.63M -26.13M -13.66M
Depreciation & Amortization 5.36M 5.14M 3.33M 1.23M 519.00K
Stock-Based Compensation 5.21M 4.55M 2.52M 515.00K 240.00K
Other Working Capital 17.66M -10.76M -5.91M 20.23M 138.00K
Other Non-Cash Items -315.00K 260.00K 9.16M 2.00K 78.00K
Deferred Income Tax - - -9.16M - -
Change in Working Capital 17.61M -10.23M -5.90M 21.36M 299.00K
Operating Cash Flow -61.36M -66.50M -48.68M -3.02M -12.52M
Capital Expenditures -3.15M -4.22M -9.94M -4.24M -1.25M
Acquisitions - - - - -
Purchase of Investments -77.61M - - - -
Sales Maturities Of Investments 20.00M - - - -
Other Investing Acitivies - - - - -
Investing Cash Flow -60.76M -4.22M -9.94M -4.24M -1.25M
Debt Repayment - 29.35M - - -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies 93.03M -191.00K 100.02M 288.00K 34.81M
Financial Cash Flow 135.44M 29.36M 189.67M 288.00K 34.81M
Net Cash Flow 13.33M -41.37M 131.05M -6.97M 21.04M
Free Cash Flow -64.50M -70.73M -58.62M -7.26M -13.77M